novo nordisk weight loss - Search News

News

CEO of Novo Nordisk, maker of weight loss drug Wegovy

The New York Times · 2d

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Yahoo Finance · 2h

Novo Nordisk’s CEO to step down as weight loss market share plummets

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor agonists (GLP-1RA) market pressure from Eli Lilly.

Associated Press News on MSN · 2d

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

3don MSN

Novo Nordisk CEO's Surprise Exit After Setbacks in Weight-Loss Market

"The Novo Nordisk Foundation is increasing its influence and has appointed its chairman, Lars Rebien Sørensen, as an observer ...

2d

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

5d

Why Weight-Loss Developer Stocks Tumbled on Tuesday

A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results